Will Democrats Slam Drug Prices? Health Care Stocks Dive Ahead Of DebateInvestors Business Daily • 06/26/19
How Much Can Johnson & Johnson's Consumer Healthcare Revenue Grow Over The Next Three Years?Forbes • 06/19/19
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug FailuresInvestors Business Daily • 06/14/19
Johnson & Johnson Is A Massive Pharma Stock — But Should You Buy It?Investors Business Daily • 06/11/19